- Plus Therapeutics (NASDAQ:PSTV) announced on Tuesday the pricing of a private placement, with gross proceeds to the company expected to be approximately $15M.
- The offering consists of 28.04M common units, each consisting of (i) one share of common stock or one pre-funded warrant, (ii) one
